These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia]. Fujimori S Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523 [TBL] [Abstract][Full Text] [Related]
3. [Is hyperuricemia involved in the pathogenesis of hypertension and renal insufficiency?]. Hadjeres S; Saudan P Rev Med Suisse; 2009 Feb; 5(192):451-2, 454-6. PubMed ID: 19317311 [TBL] [Abstract][Full Text] [Related]
4. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts. Bakris GL; Doghramji PP; Keenan RT; Silber SH Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074 [TBL] [Abstract][Full Text] [Related]
5. [Hyperuricemia and uro-nephrological disorders]. Hurtes X; Meria P Presse Med; 2011 Sep; 40(9 Pt 1):865-8. PubMed ID: 21684106 [TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia, the heart, and the kidneys - to treat or not to treat? Petreski T; Ekart R; Hojs R; Bevc S Ren Fail; 2020 Nov; 42(1):978-986. PubMed ID: 32972284 [TBL] [Abstract][Full Text] [Related]
8. Hyperuricaemia: more than just a cause of gout? Katsiki N; Karagiannis A; Athyros VG; Mikhailidis DP J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):397-402. PubMed ID: 23032963 [TBL] [Abstract][Full Text] [Related]
9. [Introduction of the new guideline for the management of hyperuricemia and gout with special reference to its policy]. Nakajima H; Matsuzawa Y Nihon Rinsho; 2003 Jan; 61 Suppl 1():442-9. PubMed ID: 12629763 [No Abstract] [Full Text] [Related]
11. Update on gout and hyperuricemia. Baker JF; Schumacher HR Int J Clin Pract; 2010 Feb; 64(3):371-7. PubMed ID: 19909378 [TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia and tissue monourate deposits: prospective therapeutic considerations. Perez-Ruiz F; Punzi L Eur Rev Med Pharmacol Sci; 2015; 19(9):1549-52. PubMed ID: 26004589 [No Abstract] [Full Text] [Related]
13. Managing new-onset gout in pediatric renal transplant recipients: when, how, to what extent. Assadi F J Nephrol; 2013; 26(4):624-8. PubMed ID: 22941874 [TBL] [Abstract][Full Text] [Related]
14. Inflammation: a possible mechanism for a causative role of hyperuricemia/gout in cardiovascular disease. Perez-Ruiz F; Becker MA Curr Med Res Opin; 2015; 31 Suppl 2():9-14. PubMed ID: 26414731 [TBL] [Abstract][Full Text] [Related]
15. Management of hyperuricemia and gout in CKD. Gaffo AL; Saag KG Am J Kidney Dis; 2008 Nov; 52(5):994-1009. PubMed ID: 18971014 [No Abstract] [Full Text] [Related]
17. Hyperuricemia, gout, and cardiovascular disease: an update. Abeles AM Curr Rheumatol Rep; 2015 Mar; 17(3):13. PubMed ID: 25740704 [TBL] [Abstract][Full Text] [Related]
18. Definition of hyperuricemia and gouty conditions. Bardin T; Richette P Curr Opin Rheumatol; 2014 Mar; 26(2):186-91. PubMed ID: 24419750 [TBL] [Abstract][Full Text] [Related]
19. Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. Franchi C; Salerno F; Conca A; Djade CD; Tettamanti M; Pasina L; Corrao S; Marengoni A; Marcucci M; Mannucci PM; Nobili A; Eur J Intern Med; 2014 Nov; 25(9):847-52. PubMed ID: 25439099 [TBL] [Abstract][Full Text] [Related]
20. Hyperuricemia, gout, and related comorbidities: cause and effect on a two-way street. Karis E; Crittenden DB; Pillinger MH South Med J; 2014 Apr; 107(4):235-41. PubMed ID: 24937517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]